Microbiological tined‐lead examination: does prolonged sacral neuromodulation testing induce infection?

To investigate whether prolonged sacral neuromodulation (SNM) testing induces a substantial risk of infection because of the percutaneous passage of the extension wire.

[1]  K. Jünemann,et al.  Urodynamic changes and response rates in patients treated with permanent electrodes compared to conventional wire electrodes in the peripheral nerve evaluation test , 2008, World Journal of Urology.

[2]  W. Poewe,et al.  Safety of prolonged sacral neuromodulation tined lead testing* , 2008, Current medical research and opinion.

[3]  M. Elhilali,et al.  Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. , 2007, The Journal of urology.

[4]  Sohier Elneil,et al.  Sacral neurostimulation for urinary retention: 10‐year experience from one UK centre , 2007, BJU international.

[5]  C. Edmiston,et al.  Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation. , 2007, Urology.

[6]  B. Schurch,et al.  Sacral Neuromodulation for Refractory Lower Urinary Tract Dysfunction: Results of a Nationwide Registry in Switzerland , 2007 .

[7]  P. V. van Kerrebroeck,et al.  Medium‐term experience of sacral neuromodulation by tined lead implantation , 2007, BJU international.

[8]  R. Dmochowski,et al.  Management of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulation , 2007, Neurourology and urodynamics.

[9]  F. Daneshgari,et al.  Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. , 2006, Urology.

[10]  R. D. de Bie,et al.  Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. , 2006, European urology.

[11]  J. Pannek,et al.  Bacterial contamination of test stimulation leads during percutaneous nerve stimulation. , 2005, Urology.

[12]  T. Kessler,et al.  Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method? , 2005, European urology.

[13]  W. Oosterlinck,et al.  A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. , 2004, European urology.

[14]  M. Spinelli,et al.  New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. , 2003, The Journal of urology.

[15]  C. Comiter.  Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. , 2003, The Journal of urology.

[16]  M M Elhilali,et al.  Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. , 2000, Urology.

[17]  M. Elhilali,et al.  Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. , 2000, The Journal of urology.

[18]  J. Bosch,et al.  Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. , 2000, The Journal of urology.

[19]  R. Gaynes,et al.  CDC Definitions of Nosocomial Surgical Site Infections, 1992: A Modification of CDC Definitions of Surgical Wound Infections , 1992, Infection Control & Hospital Epidemiology.

[20]  R. Schmidt,et al.  Bladder pacemaker: scientific basis and clinical future. , 1982, Urology.

[21]  M. Elhilali,et al.  Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. , 2001, The Journal of urology.

[22]  T. Horan,et al.  GUIDELINE FOR PREVENTION OF SURGICAL SITE INFECTION , 1999 , 1999 .